| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/26/1999 | CA2321106A1 Group b streptococcus antigens |
| 08/26/1999 | CA2320843A1 Methods using pla2 as a marker of metastases and for the diagnosis of selected cancers |
| 08/26/1999 | CA2320632A1 Caf1-related protein |
| 08/26/1999 | CA2320060A1 Skin care compositions |
| 08/26/1999 | CA2319038A1 Analgesic peptides from venom of grammostola spatulata and use thereof |
| 08/26/1999 | CA2317922A1 Exo1 and exo2, exocytotic proteins |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937463A1 Skin care compositions |
| 08/25/1999 | EP0937251A1 Purification of antigen-specific t cells |
| 08/25/1999 | EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/25/1999 | EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 08/25/1999 | EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 08/25/1999 | EP0937144A1 Human eosinophil-derived basic protein |
| 08/25/1999 | EP0937140A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 08/25/1999 | EP0937139A1 Amidase |
| 08/25/1999 | EP0937105A1 Vaccine against carbohydrate antigens |
| 08/25/1999 | EP0937102A1 Human monocyte chemotactic proprotein |
| 08/25/1999 | EP0937095A1 Targeted cytolysis of cancer cells |
| 08/25/1999 | EP0936923A1 SUPPRESSION OF TNF $g(a) AND IL-12 IN THERAPY |
| 08/25/1999 | EP0763131B1 Assay of tetanus- and botulinum toxins |
| 08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
| 08/25/1999 | CN1226897A Isolated peptides derived from mage-2 |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/24/1999 | US5942664 Isolated mutant bacillus thuringiensis cry1c delta-endotoxin polypeptide having improved insecticidal activity |
| 08/24/1999 | US5942620 Methods for producing novel conjugates of thrombin inhibitors |
| 08/24/1999 | US5942607 B7-2: a CTLA4/CD28 ligand |
| 08/24/1999 | US5942602 Growth factor receptor antibodies |
| 08/24/1999 | US5942420 Nucleic acid which encodes a follistatin module containing protein; antiproliferative agent and anticarcinogenic agent |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides |
| 08/24/1999 | US5942413 Polynucleotide fragment that codes an antigen from parasitic worms; antihelmintics |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | US5942404 Diagnosing leukemia by incubating cells with specific antibodies and detecting surface antigens |
| 08/24/1999 | US5942400 Assays for detecting β-secretase |
| 08/24/1999 | US5942393 Method for the detection of the presence or absence of methylthioadenosine phosphorylase (MTASE) in a cell sample by detection of the presence or absence of MTASE encoding nucleic acid in the cell sample |
| 08/24/1999 | US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form |
| 08/24/1999 | US5942230 Composition of immunotoxins and retinoids and use thereof |
| 08/24/1999 | US5942229 Method for prolonged suppression of humoral immune response to a thymus-dependent antigen therapeutic agent |
| 08/24/1999 | US5942227 Treating type 2 diabetes mellitus or insulin resistance patient |
| 08/24/1999 | US5942225 Comprising the stem cells and one or more bioactive factors for inducing differentiation of them into a single particular lineage, e.g. bone, muscle, tendon, ligament, connective tissue cells |
| 08/24/1999 | US5942223 Antiviral therapy using ovine or bovine interferon-tau |
| 08/24/1999 | US5942222 Administering cytokines macrophage inflammatory proteins (mip-1 and 2) capable of enhancing myelopoietic colony stimulating factor, binding to heparin, and inducing local inflammation having polymorphonuclear cell infiltration |
| 08/24/1999 | CA2248972A1 Novel compounds |
| 08/24/1999 | CA2110510C Cold tolerances in plants |
| 08/24/1999 | CA2082650C Method and apparatus for biopolymer synthesis |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041614A2 Method for detecting intimin producing microorganisms |
| 08/19/1999 | WO1999041612A1 Methods and compositions for diagnosis of hepatoma |
| 08/19/1999 | WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | WO1999041388A2 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
| 08/19/1999 | WO1999041387A2 Prostate-associated serine protease |
| 08/19/1999 | WO1999041384A1 Splice variants of p101 protein |
| 08/19/1999 | WO1999041380A1 THE REGULATORY SEQUENCE OF η-4 GERMLINE (GL) TRANSCRIPT AND ITS APPLICATIONS |
| 08/19/1999 | WO1999041377A1 Novel cystine knot protein and materials and methods for making it |
| 08/19/1999 | WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | WO1999041375A2 Human receptor proteins |
| 08/19/1999 | WO1999041374A2 Human short-chain tnf-receptor family protein |
| 08/19/1999 | WO1999041373A2 Human transport-associated molecules |
| 08/19/1999 | WO1999041370A1 Cea/nca-based differentiation cancer therapy |
| 08/19/1999 | WO1999041363A1 Podocalyxin like sialomucins having selectin ligand activity |
| 08/19/1999 | WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG |
| 08/19/1999 | WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | WO1999040940A1 Ligands of the cd47 antigen, agents binding the ligands of the cd47 antigen and uses thereof |
| 08/19/1999 | WO1999040939A1 Method for the prevention and treatment of a type i hypersensitivity disorder |
| 08/19/1999 | WO1999040934A1 Strategically modified hepatitis b core proteins and their derivatives |
| 08/19/1999 | WO1999040881A2 Specific antibodies against mammary tumor-associated mucin, method for production and use |
| 08/19/1999 | WO1999040837A2 Compositions for detecting and surgically removing lymphoid tissue involved in tumor progression |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof |
| 08/19/1999 | WO1999025380A3 Methods and compositions for the treatment of psoriasis |
| 08/19/1999 | WO1999023108A9 Inducible phosphofructokinase and the warburg effect |
| 08/19/1999 | DE19802377A1 Verwendung von Inhibitoren für die Behandlung von RTK-Überfunktions-bedingten Störungen, insbesondere von Krebs Use of inhibitors for the treatment of RTK function-related disorders, particularly cancer |
| 08/19/1999 | CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg |
| 08/19/1999 | CA2321160A1 Methods and compositions for diagnosis of hepatoma |
| 08/19/1999 | CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | CA2321105A1 Human short-chain tnf-receptor family protein |
| 08/19/1999 | CA2320753A1 Method for detecting intimin producing microorganisms |
| 08/19/1999 | CA2320427A1 Human receptor proteins |
| 08/19/1999 | CA2320424A1 Human transport-associated molecules |
| 08/19/1999 | CA2320422A1 Metalloprotease-disintegrins svph3-13 and svph3-17 dna and polypeptides |
| 08/19/1999 | CA2320391A1 Novel cystine knot protein and materials and methods for making it |
| 08/19/1999 | CA2320104A1 Method for the prevention and treatment of a type i hypersensitivity disorder |
| 08/19/1999 | CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | CA2319688A1 Specific antibodies against mammary tumor-associated mucin, method for production and use |
| 08/19/1999 | CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | CA2319098A1 Cea/nca-based differentiation cancer therapy |
| 08/19/1999 | CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity |
| 08/19/1999 | CA2312991A1 Prostate-associated serine protease |
| 08/18/1999 | EP0935757A1 Assessment of cervical cells |
| 08/18/1999 | EP0935754A1 Compositions and methods for detection of antibody binding to cells |
| 08/18/1999 | EP0935676A2 Method of identifying cytochrome p450 |
| 08/18/1999 | EP0935656A1 Hedgehog interacting proteins and uses related thereto |
| 08/18/1999 | EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 08/18/1999 | EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 08/18/1999 | EP0935612A1 Precursors of catalytic antibodies |
| 08/18/1999 | EP0935610A1 Novel human interferon-inducible protein |
| 08/18/1999 | EP0935604A1 Magnetically activated cell sorting for production of proteins |
| 08/18/1999 | EP0935470A1 Method for treating allergic lung disease |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0703925B1 Production of antibody fragments |